Multiple Myeloma | Specialty

The OncLive Multiple Myeloma condition center page is a comprehensive resource for clinical news and expert insights on multiple myeloma and how to treat patients with monoclonal antibodies, proteasome inhibitors, bispecific T-cell engagers, immunomodulatory agents, CAR T-cell therapy, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in multiple myeloma.

Dr. Pieter Sonneveld on a Prognostic Indicator for Multiple Myeloma

July 5th 2016

EC Grants Expanded Approval for Carfilzomib in Myeloma

July 4th 2016

The European Commission has approved carfilzomib in combination with dexamethasone for adult patients with multiple myeloma who have received at least one prior therapy.

Dr. Shaji Kumar on Novel Frontline Treatment Options in Multiple Myeloma

June 30th 2016

Dr. Mateos on Ixazomib-Lenalidomide-Dexamethasone in Relapsed/Refractory Multiple Myeloma

June 30th 2016

Final Thoughts on Modern Treatment of Myeloma

June 27th 2016

Emerging Therapies for Myeloma

June 27th 2016

MRD Monitoring in Multiple Myeloma

June 27th 2016

Practical Information on Immunotherapy Use

June 27th 2016

Daratumumab Revolutionizing How Myeloma Is Treated

June 27th 2016

Sequencing Therapies for Multiple Myeloma

June 27th 2016

Pomalidomide In Lenalidomide-Refractory Multiple Myeloma Patients

June 27th 2016

Therapy Based on Rapid versus Slow Progression of Myeloma

June 27th 2016

Upfront Therapy for Transplant -Ineligible Patients

June 27th 2016

Risk Stratified Treatment; Maintenance or Not?

June 27th 2016

The Ongoing Role of Transplant in Multiple Myeloma

June 27th 2016

Carfilzomib As Part of Upfront Therapy in Multiple Myeloma

June 27th 2016

Transplant-Eligible Newly Diagnosed Myeloma

June 27th 2016

When to Treat Smoldering Myeloma

June 27th 2016

New Thinking on Asymptomatic Myeloma

June 27th 2016

Dr. Jakubowiak on Improved Efficacy with ASCT+ KRd in Multiple Myeloma

June 12th 2016